Focused Wealth Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Focused Wealth Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Hold	0	–	–	–	736
2015 Q3	–	Hold	0	–	–	–	729
2015 Q2	–	Hold	0	–	–	–	637
2015 Q1	–	Hold	0	–	–	–	652
2014 Q4	–	Hold	0	–	–	–	636
2014 Q3	–	Hold	0	–	–	–	661
2014 Q2	–	Hold	0	–	–	–	644
2014 Q1	–	Sell	-1	Closed	-$4.46K	–	609
2013 Q4	$4K	Hold	1	–	–	﹤0.01%	511
2013 Q3	$4K	Buy	+1	New	+$7.5K	﹤0.01%	482

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Focused Wealth Management's FRTX Position: Q4 2015 in Review

Focused Wealth Management held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q4 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Focused Wealth Management first reported a position in FRTX in Q3 2013 and has held it in 2 quarters since. The position peaked at $4K in Q4 2013. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

Focused Wealth Management held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q4 2015.
Focused Wealth Management left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q4 2015.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Focused Wealth Management's portfolio in Q4 2015, its #736 holding.
Focused Wealth Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and has held it in 2 quarters since.
Focused Wealth Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $4K in Q4 2013.
41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Focused Wealth Management's 13F filing for Q4 2015, filed 12 Feb 2016.